Skip to content

Clinical trials

Gastrointestinal Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Country / region: Australia Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20161
20172
20202
20224
20231
20242
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting10
Active, not recruiting3
Completed3
Unknown status2
Approved for marketing1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
DualityBio Inc.2
GlaxoSmithKline2
Anthos Therapeutics, Inc.1
Arbele Pty Ltd1
Bayer1
Genmab1
Merck Sharp & Dohme LLC1
Olivia Newton-John Cancer Research Institute1
Revolution Medicines, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms20
Colorectal Neoplasms9
Stomach Neoplasms7
Carcinoma, Non-Small-Cell Lung5
Digestive System Neoplasms5
Endometrial Neoplasms5
Intestinal Neoplasms5
Neoplasms5
Pancreatic Neoplasms5
Biliary Tract Neoplasms4

Trials

Showing 51 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.